A Study to Learn How Much Rosuvastatin Gets Into the Blood When Taken With or Without Elinzanetant and to Learn About the Safety of Elinzanetant in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

July 23, 2021

Study Completion Date

September 29, 2021

Conditions

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Interventions

DRUG

Elinzanetant (BAY3427080)

Once daily over 12 days

DRUG

Rosuvastatin

Single doses on Day 1, Day 8, and Day 13

Trial Locations (1)

CRS Clinical-Research-Services Mannheim GmbH, Mannheim